Uncategorized

Regulatory Requirements for API Imports in South America

Rate this post

Understanding Pharmaceutical API Import Regulations Across South America

Importing active pharmaceutical ingredients into South America requires navigating a complex web of country-specific regulations. Each nation has its own regulatory authority, documentation requirements, and approval timelines. This guide covers the key pharma import documentation needed across major South American markets.

Country-by-Country Regulatory Overview

Brazil — ANVISA

Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA) is one of the strictest regulatory bodies in Latin America. API imports require:

  • ANVISA registration with detailed technical dossier
  • GMP inspection of the manufacturing facility by ANVISA inspectors
  • Certificate of Suitability or Drug Master File
  • Portuguese-language labeling and documentation

Argentina — ANMAT

ANMAT requires:

  • Product registration through the ANMAT portal
  • GMP certificate apostilled and translated to Spanish
  • Batch-specific Certificate of Analysis
  • Stability studies per ICH guidelines

Colombia — INVIMA

INVIMA requires sanitary registration, GMP certification, and a Certificate of Pharmaceutical Product from the exporting country.

Chile — ISP

The Instituto de Salud Pública requires ISP registration, GMP compliance, and sanitary authorization from the Health Ministry.

Peru — DIGEMID

DIGEMID mandates sanitary registration, WHO-GMP certification, and legalized documentation with apostille.

Common Documentation Required Across All Countries

Regardless of the destination country, regulatory API import operations require these core documents:

  1. Certificate of Analysis (COA) — Batch-specific with identity, assay, impurities, and residual solvents
  2. Material Safety Data Sheet (MSDS) — Safety handling and storage information
  3. GMP Certificate — WHO-GMP, US FDA, or EU GMP certification
  4. Certificate of Pharmaceutical Product (CPP) — Issued by the regulatory authority of the manufacturing country
  5. Drug Master File (DMF) — Technical dossier with manufacturing process details
  6. Stability Studies — ICH-compliant long-term and accelerated stability data
  7. Commercial Invoice and Packing List — For customs clearance

Tips for Smooth Regulatory Compliance

  • Start the registration process 6–12 months before planned shipment
  • Work with a local regulatory agent in the destination country
  • Ensure all documents are properly translated and legalized
  • Maintain an updated DMF for each API
  • Keep GMP certificates current and schedule re-inspections proactively

How Aarise Pharma Supports Regulatory Compliance

Aarise Pharma provides complete pharmaceutical compliance Latin America support including document preparation, regulatory filing assistance, and liaison with local agents across Brazil, Argentina, Colombia, Chile, and Peru.

Need help with API import documentation for South America?

📩 Contact us on WhatsApp for regulatory assistance.